Zhongchao Introduces PRO-Based Disease Management Model for Lung Cancer Patients
26 Sep 2023
This model is geared toward aiding the recovery of lung cancer patients and enhancing their life quality
The PRO-based symptom management method prioritizes genuine feedbacks from patients about their health conditions. (Credit: kalhh from Pixabay
Zhongchao, a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced the introduction of its Patient-Reported Outcome (PRO) -based symptom management model. This model is geared toward aiding the recovery of lung cancer patients and enhancing their life quality.
The PRO-based symptom management method prioritizes genuine feedbacks from patients about their health conditions, which aids in accurately identifying underlying health concerns and enhancing overall well-being. A study published in the “Journal of Clinical Oncology” in 2022 also highlighted that a PRO-driven model integrating proactive Symptom Monitoring, Alerting, and Response System can significantly reduce post-discharge symptoms and complications in lung cancer patients, accelerate their post-operative recovery and receive high satisfaction from patients.
Zhongchao’s existing patient management services already features a comprehensive range of offerings for lung cancer patients. The expert-led seminars could guide patients and offer direct engagement through mobile applications to answer their queries virtually. The seminars ensure patients fully understand their treatment journey and can enhance their adherence to treatment protocols.
Zhongchao also provides a suite of resources through mobile applications, including, among the others, educational contents, disease follow-up visits, lifestyle advice, drug aids information and other support services. To facilitate efficient and one-on-one patient communications, Zhongchao has established robust follow-up channels through various platforms such as telephones, WeChat, and text messages, staffed by dedicated disease management specialists.
Weiguang Yang, Chairman and Chief Executive Officer of Zhongchao, commented, “We believe that PRO-based symptom management method provides an invaluable way to detect lung cancer patients’ underlying health issues accurately and comprehensively, assist clinical decisions and improve the quality of care for our lung cancer patients. At Zhongchao, we are continually refining our approaches to patient management services, aiming to achieve meaningful and lasting impacts on the lives of cancer patients.”
Source: Company Press Release
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.